In that study, chronic peritoneal administration of pristane elicited increased expression of the type I interferon-inducible genes Mx1, Irf7, IP-10 and Isg-15 as a consequence of SLE [72]. The gene discussed is CXCL10; the disease is systemic lupus erythematosus.